Trial
NCT00991029
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of California, San Francisco
Collaborators
Neurological Emergencies Treatment Trials Network (NETT); Medical University of South Carolina; The Emmes Company, LLC
Condition
Ischemic Attack, Transient
Intervention
Clopidogrel
Why stopped
The trial was halted by the DSMB.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-04